MRPS10P2

Across TCGA pan-cancer cohorts, MRPS10P2 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MRPS10P2 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher MRPS10P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MRPS10P2 expression acts as an unfavorable survival marker, although some lineages such as ESCA and SKCM show a favorable association.

KICH, LUSC, and MESO are the cancer types where MRPS10P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	II,III,IV	0.589	0.909	<.001	45	view →
LUSC	DFS	Tertile	II,III,IV	0.079	0.750	<.001	36	view →
MESO	OS	Tertile	II,III,IV	0.358	0.591	.026	18	view →
KIRC	DFS	Tertile	IV	0.327	0.641	.011	18	view →
LIHC	DFS	Tertile	All	0.196	0.561	.001	18	view →
ESCA	DFS	Tertile	III,IV	0.498	0.301	.016	17	view →
SKCM	OS	Tertile	II,III,IV	0.762	0.370	.028	9	view →
LGG	OS	Tertile	All	0.974	0.873	.022	6	view →
LUAD	DFS	Tertile	III,IV	1.000	0.266	.033	6	view →
STAD	DFS	Quartile	IV	0.097	0.441	.014	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MRPS10P2–KICH (OS)

Open the KICH breakdown →